HCC BRIDGE study: Bridge to better outcomes in HCC
ID Number 09-0155Principal Investigator(s)
Myron E. Schwartz
Department(s) or Division(s)
The purpose of this study is to determine current treatment approaches and outcomes for patients with hepatocellular carcinoma (HCC). In addition to date of birth and dates of diagnosis(es), treatments, procedures, and hospitalizations, we will collect information on how patients' HCC has been treated, how well that treatment has worked, and if they experienced any reactions to their treatment. We will be sharing this information with Bristol-Myers Squibb – a company that is developing a new treatment for HCC – and they will compile the information collected from many centers worldwide into a database. This information will be used to assess the current treatment options and their related outcomes for patients with HCC.
Recruiting Patients: Yes